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Introduction
Tamm-Horsfall protein (THP) is a glycoprotein originally described by Tamm and Horsfall in 1950. 1 Although it is the most abundant urine protein under physiological conditions, its physiological role still remains unknown. Its participation in some pathological conditions of the kidney and urinary tract has been discussed. 2, 3 THP is exclusively produced by the thick ascending limb of Henle's loop. 2 Taking into account its location, phylogenetic and ontogenetic studies suggest a link of THP to specific functions of the diluting segment. 2, 4 It has been demonstrated that THP binds furosemid in a saturable fashion and depends upon the presence of Na + , K + and Cl − . 5 The binding of furosemid by THP is abnormal in diabetic patients, 6 who are prone to hypertension. Furthermore, the concentration of furosemid required for half maximal binding with THP is similar to the concentration necessary for half inhibition of Na
− cotransport in the thick ascending loop of Henle's. 7 All these facts suggest that THP may play a role in the pathophysiology of hypertension. Furthermore it was found that urinary THP excretion is the lowest in newborn children and rises until reaching maturity. THP) and age in hypertensive and normotensive elderly patients.
Materials and methods
We examined 15 young healthy controls (eight males and seven females), 15 young hypertensive patients (nine males and six females), 15 older normotensive subjects (eight males and seven females), and 31 older hypertensive patients (17 males and 14 females).
Only subjects without biochemical and clinical symptoms of impaired renal and liver function, urinary tract infection, and latent or overt circulatory failure were included in this study. Arterial hypertension was diagnosed according to WHO criteria. Normotension was defined as blood pressure below 140/90 mm Hg, and hypertension as blood pressure above 160/95 mm Hg. Mean arterial pressure (MAP) was calculated according to the following equation:
Basic clinical data of the examined subjects are listed in Table 1 .
In all subjects the following parameters were assessed: 24 h urine volume and urinary excretion of THP and creatinine, and urine specific gravity after 16 h of hydropenia. Body weight and serum creatinine were also measured.
THP was assessed by radioimmunoassay developed in this laboratory using THP antibodies raised in rabbits. 9 Sensitivity of this method is 10 ng of THP per tube. The coefficient of intra-and inter- YC = young healthy subjects; YHT = young hypertensive patients Ͻ60 years; OC = normotensive subjects Ͼ60 years; OHT = hypertensive patients Ͼ60 years. Tables 2 and 3 . As can be seen in Table 2 , urinary volume and urinary creatinine excretion was similar in all the examined groups. Specific gravity of urine in elderly normotensive and hypertensive patients was significantly lower as compared with respective younger subjects (P Ͻ 0.05). Urinary THP excretion in young hypertensive patients was of the same magnitude as in young normotensive controls. In elderly normotensive subjects U-THP was significantly lower than in young normotensive controls (P Ͻ 0.01), and hypertensive young and old patients (P Ͻ 0.01 and P Ͻ 0.05, respectively). In elderly hypertensive patients U-THP was similar to that in young controls and young hypertensive patients. As shown in Table 3 , a significant positive correlation was found between U-THP and 24-h urinary volume in all examined groups.
Results

Results are shown in
A significant negative correlation was found between U-THP and age only in elderly normotensive subjects, and a significant positive correlation between U-THP and MAP only in elderly hypertensive patients. There was no significant correlation between U-THP and urine specific gravity in all examined groups.
Discussion
As shown in this paper, urinary THP excretion in elderly normotensive subjects is significantly lower than in young healthy controls. In contrast to normotensive ones, in elderly hypertensive patients U-THP remains unchanged as compared with both young normotensive controls and hypertensive patients.
The most likely explanation for decreased U-THP in elderly normotensive subjects are physiological changes which occur with age. It is known that even in individuals without renal disease, renal function decreases with progression of age. 10 Why urinary THP excretion in elderly hypertensive patients is of the same magnitude as in young normotensive and hypertensive subjects and higher than in elderly normotensive subjects remains to be elucidated. One can speculate higher U-THP excretion in elderly hypertensive than normotensive subjects may be due to hypertension or be the cause of hypertension. As young normotensive subjects show similar U-THP to hypertensive patients, THP as a cause of hypertension seems to be unlikely. It seems that the absence of the physiological decrease of U-THP in elderly hypertensive patients is a result of renal adaptation to the hypertensive state in these patients. This hypothesis seems to be supported by at least two facts: (1) an absence of the physiological negative relationship between U-THP and age in elderly hypertensive patients; and (2) a presence of a significant positive correlation between U-THP and MAP in these patients.
As already mentioned, THP may play a role in urinary electrolyte excretion, [2] [3] [4] which is impaired in hypertensive patients. Thus one can speculate that higher U-THP in elderly hypertensive patients as compared with elderly normotensive ones reflects the presence of a renal compensatory process triggered by hypertension.
Summarising, the following conclusions may be drawn:
(1) THP urinary excretion decreases with age in healthy normotensive subjects, but not in hypertensive ones. (2) Higher U-THP in elderly hypertensives as compared with elderly normotensive subjects, seems to be the result of elevated blood pressure rather than the cause of hypertension.
